{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:59:47Z","timestamp":1790229587952,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":6447,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.fertnstert.2004.05.068","type":"journal-article","created":{"date-parts":[[2004,10,13]],"date-time":"2004-10-13T13:53:40Z","timestamp":1097675620000},"page":"973-975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"82","author":[{"given":"Melissa","family":"Kahsar-Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry R.","family":"Boots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2004.05.068_bib1","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib2","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib3","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"A85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib4","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1990"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0015-0282(98)00536-6","article-title":"Adrenal androgen excess in hyperandrogenism: relation to age and body mass","volume":"71","author":"Moran","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib6","first-page":"1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism","volume":"76","author":"Ibanez","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/eje.0.1330403","article-title":"Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response","volume":"133","author":"Lazar","year":"1993","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1071-5576(96)00044-5","article-title":"Mechanisms of steroid excess in 21-hydroxylase deficient non-classic adrenal hyperplasia","volume":"3","author":"Azziz","year":"1996","journal-title":"J Soc Gynecol Invest"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib9","first-page":"356","article-title":"Studies on changes in the concentration of serum adrenal androgens in pubertal twins","volume":"93","author":"Akamine","year":"1980","journal-title":"Acta Endocrinologica"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0026-0495(85)90023-X","article-title":"A genetic component to the variation of dehydroepiandrosterone sulfate","volume":"34","author":"Rotter","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0026-0495(88)90164-3","article-title":"Heritability of variation of plasma cortisol levels","volume":"37","author":"Meikle","year":"1988","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib12","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0026-0495(93)90126-9","article-title":"The Cincinnati Myocardial Infarction and Hormone Family Study: family resemblance for dehydroepiandrosterone sulfate in control and myocardial infarction families","volume":"42","author":"Rice","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/dna.1987.6.439","article-title":"Cloning and sequence of the human gene for P450c17 (steroid 17\u03b1-hydroxylase\/17,20 lyase): similarity with the gene for p450c21","volume":"6","author":"Picado-Leonard","year":"1987","journal-title":"DNA (NY)"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0303-7207(02)00363-5","article-title":"Androgen biosynthesis from cholesterol to DHEA","volume":"198","author":"Miller","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib15","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/hmg\/3.10.1873","article-title":"Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17","volume":"3","author":"Carey","year":"1994","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0968-0004(86)90226-4","article-title":"Promoter-specific activation of RNA polymerase II transcription by Sp1","volume":"3","author":"Kadonaga","year":"1986","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1359\/jbmr.2001.16.5.911","article-title":"A common promotor variant in the cytochrome P450c17alpha (CYP17) gene is associated with bioavailability testosterone levels and bone size in men","volume":"16","author":"Zmuda","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1210\/jc.2003-030164","article-title":"Polymorphisms in the P450 C17 (17-Hydroxylase\/17,20-Lyase) and P450 C19 (Aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women","volume":"89","author":"Somner","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib19","first-page":"185","article-title":"The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men","volume":"10","author":"Allen","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib20","first-page":"743","article-title":"The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer","volume":"10","author":"Haiman","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib21","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/carcin\/20.9.1727","article-title":"Prostate cancer risk and polymorphism in 17-hydroxylase (CYP17) and steroid reductase (SRD5A2)","volume":"20","author":"Lunn","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/1097-0215(20000801)87:3<434::AID-IJC19>3.0.CO;2-G","article-title":"A polymorphism in the CYP17 gene is associated with prostate cancer risk","volume":"87","author":"Gsur","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib23","first-page":"243","article-title":"A polymorphism in the CYP17 gene and risk of prostate cancer","volume":"11","author":"Stanford","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib24","first-page":"943","article-title":"CYP17 promoter variant associated with prostate cancer aggressiveness in African Americans","volume":"10","author":"Kittles","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/1097-0215(20011120)95:6<354::AID-IJC1062>3.0.CO;2-3","article-title":"Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer","volume":"95","author":"Chang","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/1097-0215(20010601)92:5<683::AID-IJC1255>3.0.CO;2-4","article-title":"Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population","volume":"92","author":"Yamada","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib27","first-page":"1063","article-title":"A polymorphism in the CYP17 gene increases the risk of breast cancer","volume":"57","author":"Feigelson","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2004.05.068_bib28","first-page":"4870","article-title":"Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility","volume":"59","author":"Huang","year":"1999","journal-title":"Cancer Res"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028204011288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028204011288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:24:14Z","timestamp":1777296254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028204011288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0015028204011288"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2004.05.068","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2004.05.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}